Continuous Glucose Monitoring Within Hospital: A Scoping Review and Summary of Guidelines From the Joint British Diabetes Societies for Inpatient Care
- PMID: 36444418
- PMCID: PMC10210120
- DOI: 10.1177/19322968221137338
Continuous Glucose Monitoring Within Hospital: A Scoping Review and Summary of Guidelines From the Joint British Diabetes Societies for Inpatient Care
Abstract
Increasing numbers of people, particularly with type 1 diabetes (T1D), are using wearable technologies. That is, continuous subcutaneous insulin infusion (CSII) pumps, continuous glucose monitoring (CGM) systems, and hybrid closed-loop systems, which combine both these elements. Given over a quarter of all people admitted to hospital have diabetes, there is a need for clinical guidelines for when people using them are admitted to hospital. The Joint British Diabetes Societies for Inpatient Care (JBDS-IP) provide a scoping review and summary of guidelines on the use of diabetes technology in people with diabetes admitted to hospital.JBDS-IP advocates enabling people who can self-manage and use their own diabetes technology to continue doing so as they would do out of hospital. Whilst people with diabetes are recommended to achieve a target of 70% time within range (3.9-10.0 mmol/L [70-180 mg/dL]), this can be very difficult to achieve whilst unwell. We therefore recommend targeting hypoglycemia prevention as a priority, keeping time below 3.9 mmol/L (70 mg/dL) at < 1%, being aware of looming hypoglycemia if glucose is between 4.0 and 5.9 mmol/L (72-106 mg/dL), and consider intervening, particularly if there is a downward CGM trend arrow.Health care organizations need clear local policies and guidance to support individuals using diabetes technologies, and ensure the relevant workforce is capable and skilled enough to ensure their safe use within the hospital setting. The current set of guidelines is divided into two parts. Part 1, which follows below, outlines the guidance for use of CGM in hospital. The second part outlines guidance for use of CSII and hybrid closed-loop in hospital.
Keywords: continuous glucose monitoring; inpatient; intermittently scanned glucose monitoring; type 1 diabetes; type 2 diabetes; wearable diabetes technology.
Conflict of interest statement
The author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: AL has received payments for speaking and advisory boards from Insulet, Dexcom, Abbott Diabetes Care, Novo Nordisk, Sanofi, and Institutional Research Support from Abbott Diabetes Care, Novo Nordisk. DF is the national lead for the UK diabetes care accreditation program and has received speaker honoraria from AstraZeneca, Novo Nordisk, and Sanofi Diabetes. SM is appointed to the Board of Trustees at the Diabetes Research and Wellness Foundation and is in receipt of funds from Dexcom for an investigator-initiated research study. GR has received personal fees from Abbott Diabetes Care, Sanofi Aventis, and Eli Lilly. PC has received personal fees from Abbott Diabetes Care, Dexcom, Diasend, Eli Lilly, Insulet, Medtronic, Novo Nordisk, Roche, and Sanofi Aventis. KD is the chair of the Joint British Diabetes Societies for Inpatient Care and has received speaker fees, travel or taken part in advisory boards for AstraZeneca, Sanofi Diabetes, Boehringer Ingelheim, Lilly, and Novo Nordisk. PA has no conflicts of interest.
Figures
References
-
- Lipton JA, Barendse RJ, Van Domburg RT, et al.. Hyperglycemia at admission and during hospital stay are independent risk factors for mortality in high risk cardiac patients admitted to an intensive cardiac care unit. Eur Heart J Acute Cardiovasc Care. 2013;2(4):306-313. doi:10.1177/2048872613489304. - DOI - PMC - PubMed
-
- Pickup JC, Freeman SC, Sutton AJ.Glycaemic control in type 1 diabetes during real time continuous glucose monitoring compared with self-monitoring of blood glucose: meta-analysis of randomised controlled trials using individual patient data. BMJ. 2011;343(1):d3805-d3805. doi:10.1136/bmj.d3805. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
